Almirall brand of meloxicam | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Almirall Brand Of Meloxicam
EDQM

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

Contact Supplier

dmfs-not-supported-m-2025-06-30

granules-india-limited-m-2025-07-07

Contact Supplier

Allsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

Contact Supplier

jdmfs-not-supported-m-2025-06-30

Almirall brand of meloxicam

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

91 API Suppliers, 22 USDMF, 15 CEP/COS, 8 JDMF, 16 EU WC, 32 KDMF, 21 NDC API, 37 Listed Suppliers, $ API Reference Price

91 API Suppliers
22 USDMF
15 CEP/COS
8 JDMF
16 EU WC
32 KDMF
21 NDC API
37 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

50 Drugs in Development

50 Drugs in Development

INTERMEDIATES

20 Intermediate Suppliers

20 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

337 FDF Dossiers, 64 FDA Orange Book, 69 Europe, 36 Canada, 34 Australia, 41 South Africa, 93 Listed Dossiers

337 FDF Dossiers
64 FDA Orange Book
69 Europe
36 Canada
34 Australia
41 South Africa
93 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 15MG, TABLET;ORAL - 7.5MG, SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 7.5MG/5ML, TABLET;ORAL - 15MG, TABLET;ORAL - 7.5MG, SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 7.5MG/5ML

TABLET;ORAL - 15MG
TABLET;ORAL - 7.5MG
SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SUSPENSION;ORAL - 7.5MG/5ML
TABLET;ORAL - 15MG
TABLET;ORAL - 7.5MG
SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SUSPENSION;ORAL - 7.5MG/5ML

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 3 Rochem International Inc, 8 SPI Pharma, 11 DKSH, 6 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 4 ACG Worldwide, 7 Actylis, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 20 BASF, 7 DFE Pharma, 7 Gangwal Chemicals, 2 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 3 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 27 Roquette, 1 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 4 Silverline Chemicals, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

75 Fillers, Diluents & Binders, 40 Disintegrants & Superdisintegrants, 29 Direct Compression, 26 Granulation, 22 Thickeners and Stabilizers, 20 Lubricants & Glidants, 19 Co-Processed Excipients, 16 Coating Systems & Additives, 16 Taste Masking, 13 Chewable & Orodispersible Aids, 12 Film Formers & Plasticizers, 12 Controlled & Modified Release, 10 Solubilizers, 9 Parenteral, 8 Empty Capsules, 7 Topical, 5 Rheology Modifiers, 4 Emulsifying Agents, 3 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

75 Fillers, Diluents & Binders
40 Disintegrants & Superdisintegrants
29 Direct Compression
26 Granulation
22 Thickeners and Stabilizers
20 Lubricants & Glidants
19 Co-Processed Excipients
16 Coating Systems & Additives
16 Taste Masking
13 Chewable & Orodispersible Aids
12 Film Formers & Plasticizers
12 Controlled & Modified Release
10 Solubilizers
9 Parenteral
8 Empty Capsules
7 Topical
5 Rheology Modifiers
4 Emulsifying Agents
3 API Stability Enhancers
2 Coloring Agents
1 Soft Gelatin
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 53 News #PharmaBuzz

1 Data Compilation #PharmaFlow
1 Stock Recap #PipelineProspector
53 News #PharmaBuzz

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 57 Regulatory FDF Prices, 1 Annual Reports

16 US Medicaid Prescriptions
57 Regulatory FDF Prices
1 Annual Reports

MARKET PLACE

35 APIs, 2 FDF Dossiers, 1 Intermediates

35 APIs
2 FDF Dossiers
1 Intermediates

PATENTS & EXCLUSIVITIES

81 US Patents, 4 US Exclusivities, 2 Health Canada Patents

81 US Patents
4 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 6 Others

5 EDQM
6 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 99 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

5 All

01 1Y0001035

02 1Y0001036

03 1Y0001037

04 1Y0001039

05 1Y0001080

filter CAS Number Reset all filters

5 All

01 171125-38-7

02 17305-71-7

03 3n/a

filter Reference Standard Reset all filters

5 All

01 1Meloxicam

02 1Meloxicam impurity A

03 1Meloxicam impurity B

04 1Meloxicam impurity C

05 1Meloxicam impurity D

Product Main Page

01

EDQM, Council of Europe

Meloxicam impurity D

EPS

Not Confirmed

01

EDQM, Council of Europe

EPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Meloxicam impurity D

CAS Number : n/a

Quantity Per Vial : 5 mg

Sale Unit : 1

Order Code : Y0001039

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Meloxicam impurity C

EPS

Not Confirmed

02

EDQM, Council of Europe

EPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Meloxicam impurity C

CAS Number : n/a

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : Y0001037

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Meloxicam impurity B

EPS

Not Confirmed

03

EDQM, Council of Europe

EPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Meloxicam impurity B

CAS Number : 7305-71-7

Quantity Per Vial : 5 mg

Sale Unit : 1

Order Code : Y0001036

Batch No : 2

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

EDQM, Council of Europe

Meloxicam impurity A

EPS

Not Confirmed

04

EDQM, Council of Europe

EPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Meloxicam impurity A

CAS Number : n/a

Quantity Per Vial : 5 mg

Sale Unit : 1

Order Code : Y0001035

Batch No : 2

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

EDQM, Council of Europe

Meloxicam

EPS

Not Confirmed

05

EDQM, Council of Europe

EPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CAS Number : 71125-38-7

Quantity Per Vial : 50 mg

Sale Unit : 1

Order Code : Y0001080

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!